Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-16

Clinical Trial Update: A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating pomalidomide plus dexamethasone in previously treated AL amyloidosis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Pomalidomide (Pomalidomide)

Snippet

Sponsor: Boston Medical Center | Conditions: AL Amyloidosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-12-16